Gravar-mail: Transplantation of Recombinant Vascular Endothelial Growth Factor (VEGF)(189)-Neural Stem Cells Downregulates Transient Receptor Potential Vanilloid 1 (TRPV1) and Improves Motor Outcome in Spinal Cord Injury